The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted a brand new drug software for gedatolisib in hormone receptor-positive (HR+), human epidermal...
Amongst sufferers with superior melanoma, long-term knowledge have proven {that a} customized mRNA most cancers vaccine, when mixed with the immunotherapy Keytruda...
Offering affected person training alongside individualized navigation can enhance genomic testing uptake and downstream participation in genomics-based scientific trials, in response to...
Dr. Benjamin Jon Golas of Hackensack Meridian Well being mentioned pancreatic most cancers remedy, specializing in surgical procedure, chemotherapy and radiation.Surgical procedure...
